Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Cell Signal ; 20(8): 1538-44, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18508236

ABSTRACT

Differentiation of PC12 cells by nerve growth factor (NGF) requires the activation of various mitogen-activated protein kinases (MAPKs) including p38 MAPK. Accumulating evidence has suggested cross-talk regulation of NGF-induced responses by G protein-coupled receptors, thus we examined whether NGF utilizes G(i/o) proteins to regulate p38 MAPK in PC12 cells. Induction of p38 MAPK phosphorylation by NGF occurred in a time- and dose-dependent manner and was partially inhibited by pertussis toxin (PTX). NGF-dependent p38 MAPK phosphorylation became insensitive to PTX treatment upon transient expressions of Galpha(z) or the PTX-resistant mutants of Galpha(i2) and Galpha(oA). Moreover, Galpha(i2) was co-immunoprecipitated with the TrkA receptor from PC12 cell lysates. To discern the participation of various signaling intermediates, PC12 cells were treated with a panel of specific inhibitors prior to the NGF challenge. NGF-induced p38 MAPK phosphorylation was abolished by inhibitors of Src (PP1, PP2, and SU6656) and MEK1/2 (U0126). Inhibition of the p38 MAPK pathway also suppressed NGF-induced PC12 cell differentiation. In contrast, inhibitors of JAK2, phospholipase C, protein kinase C and Ca(2+)/calmodulin-dependent kinase II did not affect the ability of NGF to activate p38 MAPK. Collectively, these studies indicate that NGF-dependent p38 MAPK activity may be mediated via G(i2) protein, Src, and the MEK/ERK cascade.


Subject(s)
GTP-Binding Protein alpha Subunits, Gi-Go/metabolism , MAP Kinase Signaling System , Nerve Growth Factor/pharmacology , Neurons/enzymology , p38 Mitogen-Activated Protein Kinases/metabolism , Animals , Extracellular Signal-Regulated MAP Kinases/metabolism , Neurons/drug effects , Neurons/metabolism , PC12 Cells , Proto-Oncogene Proteins pp60(c-src)/metabolism , Rats
2.
J Cell Sci ; 120(Pt 21): 3838-49, 2007 Nov 01.
Article in English | MEDLINE | ID: mdl-17940064

ABSTRACT

The P2X(4) receptor has a widespread distribution in the central nervous system and the periphery, and plays an important role in the function of immune cells and the vascular system. Its upregulation in microglia contributes to neuropathic pain following nerve injury. The mechanisms involved in its regulation are not well understood, although we have previously shown that it is constitutively retrieved from the plasma membrane and resides predominantly within intracellular compartments. Here, we show that the endogenous P2X(4) receptors in cultured rat microglia, vascular endothelial cells and freshly isolated peritoneal macrophages are localized predominantly to lysosomes. Lysosomal targeting was mediated through a dileucine-type motif within the N-terminus, together with a previously characterized tyrosine-based endocytic motif within the C-terminus. P2X(4) receptors remained stable within the proteolytic environment of the lysosome and resisted degradation by virtue of their N-linked glycans. Stimulation of phagocytosis triggered the accumulation of P2X(4) receptors at the phagosome membrane. Stimulating lysosome exocytosis, either by incubating with the Ca(2+) ionophore ionomycin, for normal rat kidney (NRK) cells and cultured rat microglia, or the weak base methylamine, for peritoneal macrophages, caused an upregulation of both P2X(4) receptors and the lysosomal protein LAMP-1 at the cell surface. Lysosome exocytosis in macrophages potentiated ATP-evoked P2X(4) receptor currents across the plasma membrane. Taken together, our data suggest that the P2X(4) receptor retains its function within the degradative environment of the lysosome and can subsequently traffic out of lysosomes to upregulate its exposure at the cell surface and phagosome.


Subject(s)
Exocytosis/physiology , Lysosomes/metabolism , Polysaccharides/metabolism , Receptors, Purinergic P2/metabolism , Amino Acid Motifs , Animals , Cell Line , Cell Membrane/metabolism , Endothelial Cells/cytology , Endothelial Cells/metabolism , Endothelium, Vascular/cytology , Humans , Lysosomal-Associated Membrane Protein 1/metabolism , Lysosomes/ultrastructure , Macrophages/cytology , Macrophages/metabolism , Microglia/cytology , Microglia/metabolism , Polysaccharides/chemistry , Rats , Receptors, Purinergic P2/chemistry , Receptors, Purinergic P2/genetics , Receptors, Purinergic P2X4 , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism
3.
J Biol Chem ; 282(13): 9526-9535, 2007 Mar 30.
Article in English | MEDLINE | ID: mdl-17284449

ABSTRACT

Inositol 1,4,5-trisphosphate (Ins(1,4,5)P(3)) 3-kinases (IP(3)Ks) are a group of calmodulin-regulated inositol polyphosphate kinases (IPKs) that convert the second messenger Ins(1,4,5)P(3) into inositol 1,3,4,5-tetrakisphosphate. However, what they contribute to the complexities of Ca(2+) signaling, and how, is still not fully understood. In this study, we have used a simple Ca(2+) imaging assay to compare the abilities of various Ins (1,4,5)P(3)-metabolizing enzymes to regulate a maximal histamine-stimulated Ca(2+) signal in HeLa cells. Using transient transfection, we overexpressed green fluorescent protein-tagged versions of all three mammalian IP(3)K isoforms, including mutants with disrupted cellular localization or calmodulin regulation, and then imaged the Ca(2+) release stimulated by 100 microm histamine. Both localization to the F-actin cytoskeleton and calmodulin regulation enhance the efficiency of mammalian IP(3)Ks to dampen the Ins (1,4,5)P(3)-mediated Ca(2+) signals. We also compared the effects of the these IP(3)Ks with other enzymes that metabolize Ins(1,4,5)P(3), including the Type I Ins(1,4,5)P(3) 5-phosphatase, in both membrane-targeted and soluble forms, the human inositol polyphosphate multikinase, and the two isoforms of IP(3)K found in Drosophila. All reduce the Ca(2+) signal but to varying degrees. We demonstrate that the activity of only one of two IP(3)K isoforms from Drosophila is positively regulated by calmodulin and that neither isoform associates with the cytoskeleton. Together the data suggest that IP(3)Ks evolved to regulate kinetic and spatial aspects of Ins (1,4,5)P(3) signals in increasingly complex ways in vertebrates, consistent with their probable roles in the regulation of higher brain and immune function.


Subject(s)
Calcium Signaling/physiology , Calcium/physiology , Phosphotransferases (Alcohol Group Acceptor)/metabolism , Amino Acid Sequence , Animals , COS Cells , Calcium/metabolism , Chlorocebus aethiops , Drosophila melanogaster/enzymology , HeLa Cells , Humans , Isoenzymes/metabolism , Mice , Molecular Sequence Data , Rats
5.
Biochem J ; 392(Pt 3): 435-41, 2005 Dec 15.
Article in English | MEDLINE | ID: mdl-16173920

ABSTRACT

IP3K (inositol 1,4,5-trisphosphate 3-kinase) catalyses the Ca2+-regulated phosphorylation of the second messenger Ins(1,4,5)P3, thereby inactivating the signal to release Ca2+ and generating Ins(1,3,4,5)P4. Here we have investigated the localization and activity of IP3KB and its modulation by proteolysis. We found that the N- and C-termini (either side of residue 262) of IP3KB localized predominantly to the actin cytoskeleton and ER (endoplasmic reticulum) respectively, both in COS-7 cells and in primary astrocytes. The functional relevance of this was demonstrated by showing that full-length (actin-localized) IP3KB abolished the histamine-induced Ca2+ response in HeLa cells more effectively than truncated constructs localized to the ER or cytosol. The superior efficacy of full-length IP3KB was also attenuated by disruption of the actin cytoskeleton. By transfecting COS-7 cells with double-tagged IP3KB, we show that the translocation from actin to ER may be a physiologically regulated process caused by Ca2+-modulated constitutive proteolysis in intact cells.


Subject(s)
Phosphotransferases (Alcohol Group Acceptor)/metabolism , Protein Processing, Post-Translational , Animals , Astrocytes/cytology , Astrocytes/metabolism , Calcium/metabolism , Cells, Cultured , Cytoskeleton/metabolism , Endoplasmic Reticulum/metabolism , Gene Expression Regulation, Enzymologic , Humans , Protein Transport , Rats
6.
Neurosignals ; 13(5): 248-57, 2004.
Article in English | MEDLINE | ID: mdl-15305092

ABSTRACT

With a history of several thousand years, traditional Chinese medicine has been well documented to be effective in the treatment of various disorders. We have investigated the activities of potential neuroactive compounds in traditional Chinese medicine such as Melia toosendan using an in vitro model system, rat pheochromocytoma PC12 cells. We report here that treatment of PC12 cells with a crude extract of the fruits of M. toosendan reduces cell growth in a dose-dependent manner without detectable cytotoxicity. Upon treatment with M. toosendan, PC12 cells exhibit robust neurite outgrowth, to a greater extent than that observed with nerve growth factor. Results obtained with specific kinase inhibitors and protein kinase A-deficient PC12 cells indicate that the actions of M. toosendan are mediated by the activation of protein kinase A and extracellular signal-regulated kinases.


Subject(s)
Cell Differentiation/drug effects , Cyclic AMP-Dependent Protein Kinases/metabolism , Drugs, Chinese Herbal/pharmacology , Melia/chemistry , Mitogen-Activated Protein Kinases/metabolism , Animals , Blotting, Western/methods , COS Cells/drug effects , Cell Differentiation/physiology , Cell Division/drug effects , Cell Survival/drug effects , Chlorocebus aethiops , Culture Media, Serum-Free/pharmacology , Dose-Response Relationship, Drug , Drug Interactions , Enzyme Activation/drug effects , Enzyme Inhibitors/pharmacology , L-Lactate Dehydrogenase , Nerve Growth Factor/pharmacology , Neurites/drug effects , PC12 Cells , Rats , Receptor, trkA/metabolism , Tetrazolium Salts , Thiazoles , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...